Trends in Endometriosis Management: A 10-Year US Claims Analysis.

IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Hannah Lewis, V K Parisa-Fatemeh Asad Zadeh, Luba Soskin, Jared Worful, Georgine Lamvu
{"title":"Trends in Endometriosis Management: A 10-Year US Claims Analysis.","authors":"Hannah Lewis, V K Parisa-Fatemeh Asad Zadeh, Luba Soskin, Jared Worful, Georgine Lamvu","doi":"10.1016/j.jmig.2025.09.519","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objective: </strong>To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.</p><p><strong>Design: </strong>Observational, retrospective study from 2009 to 2022.</p><p><strong>Setting: </strong>Two large US health insurance claims databases, MarketScan® and OPTUM®.</p><p><strong>Patients: </strong>Women aged 16-45 years with continuous enrollment in OPTUM® and MarketScan® and at least 2 diagnoses of endometriosis. Hysterectomy, menopause or active treatment of malignancy were exclusion criteria.</p><p><strong>Interventions: </strong>Pharmacological therapy (including OCPs, POPs, GnRH analogs, opioids), and surgical management (including laparoscopy and hysterectomy).</p><p><strong>Measurements: </strong>Frequencies, means, Time-to-event Kaplan-Meier curves, and Sankey diagrams were used to examine treatment initiation, frequencies and sequences.</p><p><strong>Main results: </strong>A total of 22,317 participants from OPTUM® and 54,630 from MarketScan® were included. Most of these patients (71.0% OPTUM®, 72.1% MarketScan®) received surgery after diagnosis of endometriosis, whereas medications were prescribed in 42.1% (OPTUM®) and 44.9% (MarketScan®). Surgery was performed as a first-line intervention in 37.6% (n=8,395, including 4,481 laparoscopies and 3,914 hysterectomies in OPTUM®) and 41.8% (n=22,858, including 13,175 laparoscopies and 9,683 hysterectomies in MarketScan®). Among first-line surgeries (n=8,395 OPTUM®, n=22,858 MarketScan®), laparoscopies accounted for over half (53.4%, n=4,481 OPTUM®; 57.6%, n=13,175 MarketScan®), while hysterectomies comprised nearly half (46.6%, n=3,914 OPTUM®; 42.4%, n=9,683 MarketScan®). Pharmacotherapy was used first-line in 49.9% (n=11,135) of OPTUM® and 45.5% (n=24,840) of MarketScan®. Opioids were used first-line in 12.5% (n=2,787) OPTUM® and 12.7% (n=6,932) MarketScan®. Pharmacological therapies were started as first-line intervention within 15-23 weeks, and surgeries were performed within 16-18 weeks after diagnosis. Those with gynecologic comorbidities had a shorter diagnosis-to-treatment interval than those with mental health and pain comorbidities.</p><p><strong>Conclusion: </strong>Therapies for endometriosis are generally started within 4-6 months of diagnosis. Surgery is used more frequently than medical management, and in the majority of cases, surgery was first-line intervention. Opioids are still frequently prescribed despite strong guidelines recommending against their use.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of minimally invasive gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jmig.2025.09.519","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study objective: To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.

Design: Observational, retrospective study from 2009 to 2022.

Setting: Two large US health insurance claims databases, MarketScan® and OPTUM®.

Patients: Women aged 16-45 years with continuous enrollment in OPTUM® and MarketScan® and at least 2 diagnoses of endometriosis. Hysterectomy, menopause or active treatment of malignancy were exclusion criteria.

Interventions: Pharmacological therapy (including OCPs, POPs, GnRH analogs, opioids), and surgical management (including laparoscopy and hysterectomy).

Measurements: Frequencies, means, Time-to-event Kaplan-Meier curves, and Sankey diagrams were used to examine treatment initiation, frequencies and sequences.

Main results: A total of 22,317 participants from OPTUM® and 54,630 from MarketScan® were included. Most of these patients (71.0% OPTUM®, 72.1% MarketScan®) received surgery after diagnosis of endometriosis, whereas medications were prescribed in 42.1% (OPTUM®) and 44.9% (MarketScan®). Surgery was performed as a first-line intervention in 37.6% (n=8,395, including 4,481 laparoscopies and 3,914 hysterectomies in OPTUM®) and 41.8% (n=22,858, including 13,175 laparoscopies and 9,683 hysterectomies in MarketScan®). Among first-line surgeries (n=8,395 OPTUM®, n=22,858 MarketScan®), laparoscopies accounted for over half (53.4%, n=4,481 OPTUM®; 57.6%, n=13,175 MarketScan®), while hysterectomies comprised nearly half (46.6%, n=3,914 OPTUM®; 42.4%, n=9,683 MarketScan®). Pharmacotherapy was used first-line in 49.9% (n=11,135) of OPTUM® and 45.5% (n=24,840) of MarketScan®. Opioids were used first-line in 12.5% (n=2,787) OPTUM® and 12.7% (n=6,932) MarketScan®. Pharmacological therapies were started as first-line intervention within 15-23 weeks, and surgeries were performed within 16-18 weeks after diagnosis. Those with gynecologic comorbidities had a shorter diagnosis-to-treatment interval than those with mental health and pain comorbidities.

Conclusion: Therapies for endometriosis are generally started within 4-6 months of diagnosis. Surgery is used more frequently than medical management, and in the majority of cases, surgery was first-line intervention. Opioids are still frequently prescribed despite strong guidelines recommending against their use.

子宫内膜异位症治疗的趋势:美国10年索赔分析。
研究目的:研究子宫内膜异位症的现实世界治疗模式及其与临床最佳实践建议的一致性。设计:2009 - 2022年的观察性、回顾性研究。两大美国健康保险索赔数据库,MarketScan®和OPTUM®。患者:年龄16-45岁的女性,持续纳入OPTUM®和MarketScan®,至少2例诊断为子宫内膜异位症。排除标准为子宫切除、绝经或积极治疗恶性肿瘤。干预措施:药物治疗(包括ocp、持久性有机污染物、GnRH类似物、阿片类药物)和手术治疗(包括腹腔镜检查和子宫切除术)。测量方法:使用频率、平均值、时间到事件的Kaplan-Meier曲线和Sankey图来检查治疗开始、频率和顺序。主要结果:共纳入来自OPTUM®的22,317名参与者和来自MarketScan®的54,630名参与者。大多数患者(71.0% OPTUM®和72.1% MarketScan®)在诊断子宫内膜异位症后接受了手术,而42.1% (OPTUM®)和44.9% (MarketScan®)的患者接受了药物治疗。手术作为一线干预的比例为37.6% (n= 8395,包括OPTUM®的4481例腹腔镜手术和3914例子宫切除术)和41.8% (n= 22858,包括MarketScan®的13175例腹腔镜手术和9683例子宫切除术)。在一线手术(n=8,395例OPTUM®,n=22,858例MarketScan®)中,腹腔镜手术占一半以上(53.4%,n=4,481例OPTUM®;57.6%,n=13,175例MarketScan®),子宫切除术占近一半(46.6%,n=3,914例OPTUM®;42.4%,n=9,683例MarketScan®)。49.9% (n= 11135)的OPTUM®患者和45.5% (n= 24840)的MarketScan®患者采用一线药物治疗。12.5% (n=2,787) OPTUM®和12.7% (n=6,932) MarketScan®的一线使用阿片类药物。15-23周内开始药物治疗作为一线干预,16-18周内进行手术治疗。患有妇科合并症的患者比患有精神疾病和疼痛合并症的患者有更短的诊断至治疗间隔。结论:子宫内膜异位症的治疗一般在诊断后4-6个月内开始。手术的使用比医疗管理更频繁,在大多数情况下,手术是一线干预措施。尽管有强烈的指导方针建议不要使用阿片类药物,但仍经常开具处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
7.30%
发文量
272
审稿时长
37 days
期刊介绍: The Journal of Minimally Invasive Gynecology, formerly titled The Journal of the American Association of Gynecologic Laparoscopists, is an international clinical forum for the exchange and dissemination of ideas, findings and techniques relevant to gynecologic endoscopy and other minimally invasive procedures. The Journal, which presents research, clinical opinions and case reports from the brightest minds in gynecologic surgery, is an authoritative source informing practicing physicians of the latest, cutting-edge developments occurring in this emerging field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信